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Abstract
Background: Intervertebral disc (IVD) degeneration and pathological changes in the spinal cord are major causes
of back pain. In addition to its well-established anti-resorptive effect on bone, calcitonin (CT) potentially exerts
protective effects on IVD degeneration in ovariectomized rats. However, possible therapeutic effects of CT on
lumbar fusion-induced adjacent-segment disc degeneration (ASDD) have not been investigated yet. In this study,
we examined the effects of CT on IVD degeneration adjacent to a lumbar fusion in ovariectomized rats.
Methods: Posterolateral lumbar fusion (PLF) at L4–5 was performed 4 weeks after ovariectomy (OVX) or sham
surgery in female Sprague–Dawley rats. Following PLF + OVX, rats received either salmon CT (OVX + PLF + sCT,
16 IU/Kg/2d) or vehicle (OVX + PLF + V) treatment for 12 weeks; the remaining rats were divided into Sham + V,
OVX + V, and PLF + V groups. Fusion status was analyzed by manual palpation and radiography. Adjacent segment
disc was assessed by histological, histomorphometric, immunohistochemical analysis. L6 vertebrae microstructures
were evaluated by micro-computed tomography.
Results: Histological analysis showed more severe ASDD occurred in OVX + PLF + V rats compared with the OVX +
V or PLF + V groups. CT treatment suppressed the score for ASDD, increased disc height, and decreased the area of
endplate calcification. Immunohistochemical staining demonstrated that CT decreased the expression of collagen
type-I, matrix metalloproteinase-13, and a disintegrin and metalloproteinase with thrombospondin motifs-4,
whereas it increased the expression of collagen type-II and aggrecan in the disc. Micro-computed tomography
indicated that CT increased bone mass and improved the microstructure of the L6 vertebrae.
Conclusions: These results suggest that CT can prevent ASDD, induce beneficial changes in IVD metabolism, and
inhibit deterioration of the trabecular microarchitecture of vertebrae in osteoporotic rats with lumbar fusion.




1Orthopaedic Research Institution of Hebei, Third Hospital of Hebei Medical
University, Shijiazhuang 050017, P.R. China
3Department of Orthopedic Surgery, Affiliated Hospital of North China
University of Science and Technology, No. 73 Jianshe South Rd., Tangshan,
Hebei 063000, P.R. China
Full list of author information is available at the end of the article
© 2015 Liu et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Liu et al. BMC Musculoskeletal Disorders  (2015) 16:342 
DOI 10.1186/s12891-015-0788-7
Background
Lumbar fusion is increasingly performed as the treat-
ment of choice for various degenerative disorders of the
lumbar spine [1–3]. Adjacent-segment disc degeneration
(ASDD) is a problematic complication that can occur
following lumbar spinal fusion [4, 5]. Within 5 years of
lumbar fusion surgery, the clinical incidence of symp-
tomatic ASDD was reported as 5.2–18.5 % [6]. Thus, the
prevention of ASDD after spinal fusion is a challenge
that needs to be addressed.
Large numbers of patients undergoing lumbar fusion
are the late-middle-aged and elderly population being
treated for osteoporosis, which is characterized by a sys-
temic impairment of bone mass and microarchitecture
that increases the propensity of fragility fractures due to
rapid bone absorption. It would be interesting if a treat-
ment for osteoporosis could also be effective for pre-
venting ASDD after spinal fusion. As an anti-resorptive
agent, calcitonin (CT) acts on osteoclasts to inhibit
bone resorption and is currently widely used in clinical
practice to treat osteoporosis and other diseases involv-
ing accelerated bone turnover [7, 8]. In addition to its
anti-resorptive effect on bone, a previous study revealed
that CT reduced biochemical markers of cartilage deg-
radation [9]. Moreover, our previous study confirmed
the protective effects of CT on intervertebral disc
(IVD) degeneration in osteoporotic rats [10]. However,
to our knowledge, there are no available data on the
effect of CT on ASDD induced by lumbar fusion in the
ovariectomized rat.
The structure of the endplate facilitates important bio-
mechanical and nutritional functions. Biomechanically,
the endplate is subjected to significant loads during ac-
tivities of daily living as the trunk muscles contract to
stabilize posture. Nutritionally, the endplate is the pri-
mary pathway for transport between vertebral capillaries
and cells within the disk nucleus [11]. Endplate sclerosis,
which impacts the biomechanical properties, has long
been thought to play a role in disc degeneration by de-
creasing nutrient availability to the disc; disc degener-
ation occurs concomitantly with marked architectural
bony changes on the endplate surface [12]. Moreover,
as the gateway of nutrient supply, the vertebral end-
plate is essential to maintain the integrity and function
of the avascular IVD, with increased degeneration in
the adjacent IVD being associated with greater endplate
thickness [13].
Extracellular matrix (ECM) metabolism plays a key
role in the integrity and function of theintervertebral
disc. Collagen type II (Coll-II) and aggrecan content is
crucial to proper disc function. During degeneration, the
synthesis of ECM components changes, leading to an
increase in the synthesis of Collagen type I (Col-I) and
decreased production of aggrecan. Linked tothis is an
increased expression of matrix-degrading molecules, in-
cluding matrix metalloproteinases (MMPs), aggrecanases,
and a disintegrin and metalloproteinase with thrombos-
pondin motifs (ADAMTS) −1, −4, −5, −9, and −15, all of
which are produced by native disc cells [14]. For further
insight into the mechanism of action of CT on disc ECM
metabolism, we explored whether aggrecan, Col-II, Col-I,
MMP-13, and ADAMTS-4 participate in this process.
The aim with the study was to determine whether CT,
a commonly prescribed anti-osteoporotic agent, could
not only prevent bone loss, but also retard IVD degener-
ation adjacent to the fused lumbar spine in the ovariec-
tomized rat, by detecting the fusion status, bone mass
and microstructure of the vertebrae, and by evaluating
the intervertebral disc degeneration through histology,
disc height and endplate calcification measurement,
and immunohistochemistry (IHC) analysis for aggrecan,
Col-II, Col-I, MMP-13, and ADAMTS-4.
Methods
Animal handling and study design
A total of 50, 3-month-old, female Sprague–Dawley rats
(260 ± 16 g, Peking University Animal Center, Beijing,
China) were used in this study. All animals were housed
at 20 °C with a 12-h light/dark cycle and free access to
water and food. All experimental procedures were
approved by the Institutional Animal Care and Use
Committee of North China University of Science and
Technology.
All rats received either Sham (n = 20) surgery or bilat-
eral ovariectomy (OVX) (n = 30). Four weeks after sur-
gery, all but ten10 rats from each group underwent
Posterolateral lumbar fusion (PLF) at L4–L5 [15]. Rats
received both OVX and PLF were treated by either
(1) saline vehicle treatment (OVX + PLF + V, n = 10);
or (2) subcutaneous injection of salmon CT (Novartis
AG, Switzerland) at a dose of 16 IU/kg per 2 days
(OVX + PLF + sCT, n = 10). The remaining rats from
each group received saline vehicle treatment and were
divided into three groups of 10 each: Sham +V, OVX +V,
and PLF + V. The weight of each animal was recorded
weekly and the quantity of drug was adjusted according to
the new weight recordings. After 12 weeks of treatment,
all animals were sacrificed.
After scarification, radiographic evaluation and manual
palpation were performed to evaluate the lumbar fusion,
and then the segment of the rat L3–L6 spine was re-
moved and scanned by dual energy X-ray absorptiometry
to determine bone mineral density (BMD). Five samples
from the L6 segment from each group were prepared
for micro-computed tomography analysis, while the
remaining samples were used for paraffin sectioning,
followed by van Gieson staining and immunohisto-
chemical staining.
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Evaluation of lumbar fusion
First, an anteroposterior plain soft radiograph (DR7500
System, Kodak, USA) of the spine was performed to
evaluate spinal fusion, and then imaging scores were
graded using the criterion described by O’Loughlin
et al. [16], as follows: 0, no bone; 1, poor new bone for-
mation; 2, moderate new bone formation and definite
pseudarthrosis; 3, moderate new bone formation and
possible pseudarthrosis; 4, good new bone formation
and probable fusion; 5, definite fusion. After radio-
graphic assessment, fusion status in the lumbar spine
was manually palpated, as described by Abe et al. [17].
Each spine was assessed and graded as fixed or not
fixed in a blinded manner. The lack of motion was de-
fined as successful fusion.
Bone mineral density assessment
BMD of L3–L6 was performed on the anteroposterior
plane by dual energy X-ray absorptiometry using a
densitometer (QDR Discovery, Hologic, Bedford, MA,
USA) operating at high-resolution mode, using special-
ized software for small animals supplied by the equip-
ment manufacturer.
Micro-computed tomography analysis
Three-dimensional (3D) analysis was performed on the
trabeculae of the cancellous tissue of the L6 vertebrae.
Samples were scanned by SkyScan 1076 Micro-CT
(SkyScan, Aartselaar, Belgium) with a resolution of
36 μm per voxel. The data were collected at 100 kV
and 100 μA. The volume of interest was defined as
being restricted to an inner cylinder with a 1.5-mm
diameter and a 3-mm length (1–4 mm proximal to the
growth plate), excluding the cortex, which is consistent
with our previous study. The 3D images and bone histo-
morphometry indices were calculated by the built-in soft-
ware within the machine, followed by comparing the
difference between two groups. The following 3D mor-
phometric parameters were calculated to describe the
bone mass and microstructure: BMD, the percent bone
volume (BV/TV), trabecular thickness (Tb.Th), trabecular
number (Tb.N), trabecular separation (Tb.Sp), and struc-
tural model index (SMI).
Histological and histomorphometric analysis of the L5-6
segments
The L5–L6 segments of the lumbar spine were fixed in
10 % neutral buffered formalin, decalcified in 10 % EDTA-
2Na for 3 months, split down at the mid-sagittal plane
with a scalpel, and embedded in paraffin. Samples were
then cut into 5-μm-thick parasagittal plane sections,
placed on microscope slides and stained with van Gieson
(VG) stain for light microscopic examination. Images were
captured on a BX53 microscope system (Olympus, Japan).
The degenerative changes in L5-6 segment were assessed
using the disc degeneration assessment scoring system
(Table 1) described by Wang et al. [18].
Disc height measurements were taken from the caudal
aspect of the growth plate of L5 to the cranial aspect of the
growth plate of L6 on histological samples from the L5-6
segments. For each image, an average of three measure-
ments were made from three areas of the disc space for
one section from each rat: one from the anterior, one from
the central, and one from the posterior side [19]. The
thickness of endplate was measured from the cranial
growth plate to the border between the nucleus pulposus
and the endplate in the VG staining. The ratio of calcified
area to the total endplate area were determined by an
average of 10 measurements made in the endplate, with
the semi-automatic digitizing system mentioned above.
All measurements were performed using a digital image
analysis system (BX53, Olympus, Japan).
Immunohistochemical analysis
Immunohistochemistry for Coll-I, Coll-II, aggrecan, MMP-
13 and ADAMTS-4 was performed using SA1024 SABC-
POD kit (Boster Co., Ltd., Wuhan, China) and Kit-0017
DAB detection kit (Maxim Co., Ltd. Fuzhou, China). Tis-
sue sections from L5 to L6 segments were deparaffinized
in xylene and rehydrated in a reverse-graded series of
ethanol. After antigen retrieval, quenching of endogenous
peroxidase and blocking of non-specific binding, sections
were incubated with primary antibodies (Boster, Wuhan,
China) overnight at 4 °C. Then, sections were incubated in
biotinylated secondary antibodies at 37 °C for 20 min,
followed by incubation for 20 min with SABC-Peroxidase
solution at 37 °C, and developing using a DAB kit under
the microscrope. Sections were counter stained with
hematoxylin. Samples appearing yellow or brownish-
Table 1 Lumbar intervertebral disc degeneration assessment scoring system
Score Nucleus pulposus Annulus fibrosus Osteophyte
0 Bulging gel with abundant notochordal cells Compactfibrous lamellas Absence
1 Notochordal cells loss; chondrocyte-like cells emergence Proliferation offibrocartilaginous tissue and loss of
nuclear–annular border
Appearance
2 Focal mucoid degeneration; clefts Fissures in annulusfibrosis Overgrowth
3 Diffuse mucoid degeneration and clefts throughout nucleus
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yellow were considered as positive staining. All sections
were semi-quantitatively analyzed by Image Pro Plus (IPP)
version 6.0 software, and the integrated optical density
(IOD) was measured from staining of six fields for each
section, using one section per rat, on the images at
400× magnification. The average IOD from three ob-
servers was the final observation result and used for
statistical analysis.
Statistical analysis
All data were analyzed using SPSS 19.0 software and re-
sults are expressed as mean ± standard deviation. The
statistical significance between groups was estimated
using one-way analysis of variance and the Fisher’s pro-
tected least significant difference test. The results of the
histological and radiography scores were analyzed using




As shown in Fig. 1, a lower radiographic density was ob-
served in OVX+ PLF + V rats compared with the PLF + V
and OVX+ PLF + sCT groups. The radiographs revealed
that bone formation activity had increased in the OVX +
PLF + sCT group compared with the OVX + PLF + V
group, with a significantly greater amount of fusion mass.
The radiographic scores indicated a delayed fusion process
in OVX + PLF + V (2.15 ± 0.88) rats, which was signifi-
cantly lower than the PLF + V (3.00 ± 0.92) (P = 0.043) and
OVX+ PLF + sCT (3.20 ± 0.9) groups (P = 0.013).
BMD of L3–L6 vertebrae
The same trends in the differences in BMD of the L3–L6
vertebrae were seen between any two of all five groups
(Table 2). Rats in the OVX + V (vs. Sham + V: P < 0.001,
P = 0.001, P < 0.001, P = 0.003) and OVX+ PLF + V groups
(vs. PLF + V: P < 0.001, P = 0.002, P = 0.024, P = 0.015)
exhibited significantly lower BMD compared with the
Sham+V and PLF +V groups; while OVX+ PLF + sCT rats
showed significantly higher BMD compared with OVX+
PLF +V rats (P < 0.001, P = 0.001, P = 0.004, P = 0.011).
Microstructural parameters of the L6 vertebrae
Three-dimensionally reconstructed micro-CT images are
shown in Fig. 2. Micro-computed tomography showed
that BV/TV, Tb.Th, and Tb.N were significantly lower,
and Tb.Sp and SMI were significantly higher in the
OVX + V (vs. Sham + V: P < 0.001, P < 0.001, P = 0.002,
P < 0.001, P < 0.001) and OVX + PLF + V groups (vs.
Table 2 BMD values among the five groups (Mean ± SD, g/cm2, n = 10)
Group Sham + V OVX + V PLF + V OVX + PLF OVX + PLF + CT
L3 0.3399 ± 0.0090 0.2995 ± 0.0250* 0.3201 ± 0.0110 0.2907 ± 0.0288*# 0.3219 ± 0.0271■
L4 0.3533 ± 0.0180 0.3089 ± 0.0214* 0.3418 ± 0.034 0.3039 ± 0.0221*# 0.3377 ± 0.036■
L5 0.3768 ± 0.0131 0.3295 ± 0.0223* 0.3561 ± 0.0351 0.3272 ± 0.0186*# 0.3580 ± 0.0309■
L6 0.3983 ± 0.0198 0.3681 ± 0.0191* 0.3808 ± 0.0248 0.3507 ± 0.0198*# 0.3718 ± 0.0199■
Note: *P < 0.05 vs.Sham + V group; #P < 0.05 vs. PLF + V group; ■P < 0.05 vs.OVX + PLF + V group;
Fig. 1 Representative radiographic images (a) and X-ray scores (b) of the three groups underwent lumbar fusions at 12 weeks post-PLF. The PLF
was performed at the L4-5 segment using an intertransverse process fusion with an autologous iliac bone graft and spinous-process wire fixation.
The OVX + PLF + sCT group showed a higher radiographic density than the OVX + PLF + V group. Note: #P = 0.043 vs. PLF + V group; ■P = 0.013 vs.
OVX + PLF + V group
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Sham+V: P < 0.001(all parameters); vs. PLF +V: P < 0.001,
P < 0.001, P = 0.001, P < 0.001, P < 0.001) compared
with the Sham + V and PLF + V groups. CT-treated
rats had markedly higher BV/TV, TB.Th, and Tb.N and
lower Tb.Sp and SMI compared with the OVX + PLF + V
group (P < 0.001, P = 0.039, P = 0.048, P = 0.043, P < 0.001)
(Table 3).
Histological and histomorphometric findings in L5-6
vertebral discs
The Sham + V group appeared to exhibit abundant
notochordal cells and surrounding extracellular matrix
in the nucleus pulposus, well-arranged outer annulus
fibrosus, and the endplate was rich in hyaline cartilage.
The OVX+V, PLF + V, and OVX+ PLF + V groups expe-
rienced degeneration of the nucleus pulposus, annulus
fibrosus, and endplate. Loss of cellularity of notochordal
cells and their replacement by chondrocyte-like cells were
found in the nucleus pulposus, and the matrix displayed
mucoid degeneration. Loss of collagen, proliferation of
fibrocartilaginous tissue, and disruption of the nuclear-
annular border were observed in the annulus fibrosus.
The endplate exhibited large areas of calcification to dif-
ferent degrees. These mineralized tissues became more
obvious in the deep zone of the middle cartilage end-
plate. All degenerative changes were more obvious in the
OVX + PLF + V group compared with the OVX +V or
PLF +V groups (Fig. 3).
Accordingly, the histological score in the OVX + V,
PLF + V, OVX + PLF + V, and OVX + PLF + sCT groups
were markedly higher (P < 0.001, P < 0.001, P < 0.001,
P < 0.001) than the Sham + V group; the highest value
was found in the OVX + PLF + V group, which was
significantly different compared with any other group
(vs. all group: P < 0.001) (Fig. 4).
The disc height in the OVX + V, PLF + V, and OVX +
PLF + V groups were all decreased (P < 0.0019, P <
0.001, P < 0.001) compared with the Sham + V group,
and the opposite trends were found in endplate
thickness (P < 0.001, P = 0.005, P < 0.001) and ratio of cal-
cified area to total endplate area (P = 0.048, P < 0.001, P <
0.001). The OVX+ PLF + V group showed the most ser-
ious degenerative changes, with the lowest disc height,
highest endplate thickness, and largest ratio of calcified
area to the total endplate area (vs. Sham + V: P <
0.001, P < 0.001, P < 0.001). sCT treatment markedly
prevented these degenerative changes, indicated by
the significantly higher disc height, lower endplate
thickness, and decreased ratio of calcified area to the
total endplate area, compared with the OVX + PLF + V
group (P = 0.003, P = 0.014, P = 0.001) (Fig. 5).
Immunohistochemical staining
As shown in Figs. 6 and 7, in the Sham + V group, aggre-
can and Col-II expressions were extensive in the nucleus
pulposus and annulus fibrosus, with weak expression of
Table 3 Microarchitecture parameters of vertearal body by micro-CT analysis (Mean ± SD, n = 5)
Group Sham + V OVX + V PLF + V OVX + PLF + V OVX + PLF + sCT
BMD (mg/cc) 496.04 ± 24.01 397.06 ± 21.81* 480.21 ± 18.94 370.83 ± 17.58*# 420.47 ± 21.48■
BV/TV (%) 42.62 ± 3.30 28.33 ± 2.03* 40.68 ± 0.94 26.26 ± 3.29*# 31.72 ± 4.13■
Tb.Th (μm) 83.68 ± 3.31 59.55 ± 5.28* 79.11 ± 2.05 57.14 ± 5.67*# 64.17 ± 3.46■
Tb.N (mm−1) 5.27 ± 0.3 4.45 ± 0.4* 4.96 ± 0.5 4.25 ± 0.4*# 4.65 ± 0.5■
Tb.Sp (μm) 110.83 ± 13.47 157.49 ± 18.80* 124.84 ± 14.84 168.48 ± 17.48*# 142.41 ± 18.35■
SMI 0.57 ± 0.27 1.42 ± 0.14* 0.62 ± 0.12 1.54 ± 0.13*# 1.20 ± 0.18■
Note: *P<0.05 vs.Sham + V group; #P<0.05 vs. PLF + V group; ■P<0.05 vs.OVX + PLF + V group;
Fig. 2 Representative micro-CT images of the L6 vertebrae in different groups. The morphology of the trabeculae was rod-shaped, and the width
of the canal between trabeculae was increased in the OVX + V and OVX + PLF + V groups compared with the Sham + V group. The OVX + PLF + sCT
group showed increased trabecular thickness and decreased canal width between the trabeculae compared with the OVX + PLF + V group
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MMP-13, ADAMTS-4, and Col-I compared with the
OVX + V, PLF + V, and OVX + PLF + V groups. OVX +
PLF + sCT rats exhibited stronger aggrecan and Col-II
expressions and weak MMP-13, ADAMTS-4, and Col-I
expressions compared with OVX + PLF + V rats.
Accordingly, the quantitative IOD values confirmed
these differences. Compared with the Sham + V group,
the levels of aggrecan and Col-II were significantly lower,
and MMP-13, ADAMTS-4, and Col-I were significantly
higher in the OVX + V, PLF + V, and OVX + PLF + V
groups in the nucleus pulposus and annulus fibrous
(Fig. 5). CT can significantly increase the levels of Col-II
and aggrecan (NP: P < 0.001, P = 0.001; AP: P = 0.001,
P = 0.004), and decrease the levels of MMP-13,
ADAMTS-4, and Col-I (NP: P < 0.001, P < 0.001, P < 0.001;
AP: P < 0.001, P < 0.001, P < 0.001) (Fig. 8).
Discussion
To our knowledge, this is the first study to determine
the effects of CT on ASDD induced by posterolateral
lumbar fusion in an ovariectomized rat model. Based
on the histological and histomorphometric results,
the present study demonstrates that osteoporosis in-
duced by ovariectomy exacerbates posterolateral lum-
bar fusion-induced ASDD. More importantly, in addition
to preserving vertebral BMD and trabecular bone micro-
structure, treatment with CT can prevent histological de-
generation in the adjacent disc, as well as the thickening
of the endplate and the increased ratio of calcified end-
plate area to total endplate area. CT can also inhibit the
changes in ECM metabolism by counteracting the upregu-
lation of MMP-13, ADAMTS-4, and Col-I and inhibition
of aggrecan and Col-II expression in the IVDs of OVX +
PLF +V rats.
Fig. 4 Histological scores of the L5-6 intervertebral disc at 12 weeks
after PLF. the histological score in the OVX + V, PLF + V, OVX + PLF + V,
and OVX + PLF + sCT groups were markedly higher than the Sham+ V
group; the highest value was found in the OVX + PLF + V group, which
was significantly different with OVX + PLF + sCT group. Note: *P < 0.001
vs. Sham + V group; ▲P < 0.001 vs. OVX + V group; #P < 0.001 vs.
PLF + V group; ■P = 0.001 vs. OVX + PLF + V group
Fig. 3 Van Gieson staining of the L5-6 segments of the lumbar spine in different groups. a Low magnification. b The degenerative changes in
the nucleus pulposus. The blank arrow indicates notochord cells, the thin arrow indicates mucoid degeneration of the nucleus pulposus. and the
thick arrow indicates doublets of chondrocyte-like cells that appeared in the nucleus pulposus. c The degenerative changes in the middle cartilage
endplate. Bony tissues were more prevalent in the OVX + PLF + V group compared with the Sham+ V, OVX + V, and PLF + V groups. VP, vertebral
physis; CEP, cartilage endplate; B, bony tissues
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Fig. 6 Immunohistochemistry assay for a Col-I, b Col-II, c Aggrecan, d MMP-13, and e ADAMTS-4 in the nucleus pulposus in different groups
(40×). Immunohistological analysis showed that the protein expression of Col-II and Aggrecan in the OVX + PLF + sCT group was higher than that
in the OVX + PLF + V group. Col-I-, MMP-13-, and ADAMTS-4-positive staining in the nucleus pulpous was weaker in the OVX + PLF + sCT group
compared with the OVX + PLF + V group
Fig. 5 The disc height , endplate thickness and the ratio of calcified area to endplate area of the endplate of L5-6 disc. Compared with the Sham + V
group, the disc height in the OVX + V, PLF + V, and OVX + PLF + V groups were all decreased and the opposite trends were found in endplate thickness
and ratio of calcified area to total endplate area. The OVX + PLF + V group showed the most serious degenerative changes, with the lowest disc height,
highest endplate thickness, and largest ratio of calcified area to the total endplate area. sCT treated rats showed significantly higher disc height, lower
endplate thickness, and decreased ratio of calcified area to the total endplate area, compared with the OVX + PLF + V group. Note: *P < 0.05 vs.
Sham + V group; ▲P < 0.05 vs. OVX + V group; #P < 0.05 vs. PLF + V group; ■P < 0.05 vs. OVX + PLF + V group
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ASDD after spinal fusion has been well documented in
previous studies. Phillips et al. [20] reported that spinal
fusion, created using methylmethacrylate and wire,
caused IVD degeneration at adjacent segments 6 months
after surgery in rabbits. Higashino et al. [21] showed
ASDD occurred 12 months after spinal fusion surgery.
These degenerative changes in the adjacent discs after
spinal fusion were confirmed in the present study. In
contrast, in our previous study we confirmed IVD de-
generation occurred in OVX rats. The data provided in
the present study demonstrates that rats receiving both
OVX and PLF surgeries displayed more serious ASDD
than those receiving only OVX or PLF, indicating that
the combination of OVX and PLF exacerbates ASDD.
Further study is needed to determine whether there is a
synergistic effect between or only a cumulative effect of
the two causative factors.
The present study showed an increased ratio of calci-
fied endplate area to total endplate area and greater end-
plate thickness in OVX, PLF, and OVX + PLF + V
groups, with the OVX + PLF + V group showing much
higher values than the other two groups. These histo-
morphometric changes were partially prevented by CT
treatment, thus indicating a protective effect of CT
against endplate degeneration, making it beneficial for
maintaining the biomechanical environment and nutri-
tion status of the IVD.
For further insight into the mechanism of action of
CT on disc ECM metabolism, we explored whether
aggrecan, Col-II, Col-I, MMP-13, and ADAMTS-4 par-
ticipate in this process. Compared with Sham + V rats,
decreased expression levels of Col-II and aggrecan, along
with increased levels of Col-I, MMP-13, and ADAMTS-
4, were observed in OVX + PLF + V rats. In contrast, CT
Fig. 7 Immunohistochemistry assay for a Col-I, b Col-II, c Aggrecan, d MMP-13, and e ADAMTS-4 in the annulus fibrosus in different groups (40×).
Col-I-, MMP-13-, and ADAMTS-4-positive staining in the annulus fibrosus was weaker in the OVX + PLF + sCT group compared with the
OVX + PLF + V group. Col-II- and Aggrecan-positive staining in the annulus fibrosus was stronger in the OVX + PLF + sCT group compared
with the OVX + PLF + V group
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treatment thoroughly reversed these changes in expres-
sion levels, indicating that the protective effects of CT
on ASDD in this model were, at least in part, due to
modulation of the synthesis and degradation of ECM.
In addition to the direct evidence supporting the pre-
ventive effect of CT on the histological changes of
ASDD, we also found decreased BMD and deterioration
of the vertebral trabecular bone microstructure were
observed in OVX + PLF + V rats, which were success-
fully counteracted by CT treatment. However, the rela-
tionship between BMD and disc degeneration is still
debatable. Some previous studies have supported that
higher BMD of the vertebral body is associated with
more severe adjacent disc degeneration [22], whereas
lower lumbar spine BMD was associated with less se-
vere disc degeneration [23]. It has also been noted that
relative estrogen deficiency likely contributes to accel-
erated disc degeneration in post-menopausal women
[24, 25]. The reason for this contradiction may be the
biological function of estrogen. Estrogen deficiency, as
was similarly induced in the OVX model in the present
study, is not only the main cause of bone loss, but is also
accompanied by a progressive proinflammatory status, ev-
idenced by increased systemic interleukin (IL)-1, IL-6, and
tumor necrosis factor-α [26], which are potentially import-
ant in the pathogenesis of intervertebral disc degeneration
[27, 28]. Furthermore, the structural integrity of the verte-
bral body might play an important role in the progression
of disc degeneration, whereby aberrant loading can give
rise to localized tissue injury [29]. The altered trabecular
structure of the osteoporotic spine leads to an increased
vulnerability of its biomechanical characteristics and
reduction of load resistance. Therefore, it should be rea-
sonable to consider that the preservation of the micro-
structure of the vertebral body trabecular bone may
contribute to the preventive effects of CT on ASDD in
OVX+ PLF + V rats.
It is interesting that, although it causes ASDD, lumbar
fusion was enhanced by CT treatment in the present study.
This result is similar to other previous studies [30, 31].
Babat et al. [30] found that rates of L5–L6 posterolateral
fusion with autografts in rabbits were 68 % when CT was
administered compared with 56 % in controls. Liu et al.
[31] reported that CT enhanced lumbar spinal fusion in a
New Zealand rabbit model. Based on the histological and
histomorphometric results shown in the present study, the
enhanced lumbar fusion does not affect the protective ef-
fect of CT on the IVD. It should be highlighted that CT
may be used as a dual-effect treatment for not only lumbar
fusion, but also ASDD in osteoporosis.
Conclusions
Taken together, our results indicate that CT treatment
inhibits ASDD in OVX rats, with the underlying mech-
anism possibly being associated with regulation of the
expression of aggrecan, Col-II, Col-I, MMP-13, and
ADAMTS-4, and, conversely, preservation of BMD and
trabecular bone microstructure of the adjacent vertebrae.
Remarkably, this beneficial effect on the IVD is accom-
panied with an enhancement of lumbar fusion. Though
further study was needed to confirm whether the dosage
of CT used in the present study, which was effective in
reducing bone turnover and partially preventing cancel-
lous bone loss in the estrogen-depleted skeleton [32, 33],
Fig. 8 The IOD of Col-I (a), Col-II (b), Aggrecan (c), MMP-13 (d), and ADAMTS-4 (e) in the nucleus pulposus and annulus fibrosus. Compared with
the Sham + V group, the levels of aggrecan and Col-II were significantly lower, and MMP-13, ADAMTS-4, and Col-I were significantly higher in the
OVX + V, PLF + V, and OVX + PLF + V groups in the nucleus pulposus and annulus fibrous. OVX + PLF + sCT group showed significantly higher
levels of Col-II and aggrecan and lower levels of MMP-13, ADAMTS-4, and Col-I in comparison with OVX + PLF + V group. Note: *P < 0.05 vs. Sham
+ V group; □P < 0.05 vs. OVX + V group; #P < 0.05 vs. PLF + V group; ■P < 0.05 vs. OVX + PLF + V group
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is safe for clinical patients, CT may be a potentially ef-
fective treatment for ASDD in postmenopausal osteo-
porotic patients.
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